glp 1 agonist comparison Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis Compare GLP-1 Options | Ozempic
Description
Semaglutide Phase 2 Trial: 59% NASH resolution at 0.4 mg/day Building upon the foundation established by the LEAN trial, researchers subsequently conducted a larger phase 2 trial evaluating semaglutides efficacy in NASH patients
doi: 10.1172/JCI75276
Further research is needed to identify and manage possible side effects, such as the effects on gastric emptying and the need for safety precautions during anesthesia
While its true that cardio initially may burn more calories, which can support weight loss, muscle is much more metabolically active than fat
